Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelin Receptor Antagonism in Systemic Vasculitis
NCT02062346Completed
- Sponsor
- University of Edinburgh
- Start
- Aug 2016
- Primary completion
- Jan 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of BQ-123 and BQ-788 in Systemic Vasculitis (SV) (4 arms), sponsored by University of Edinburgh. Primary endpoints: Forearm blood flow at 20 minutes and Pulse wave velocity at 4 hours. Started Aug 2016; status: completed.
02
Drugs
BQ-123BQ-788
03
Conditions
Systemic Vasculitis (SV)
Beyond the preview
Go deeper on NCT02062346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062346.